GLO-Surgery (Kidney tumor, soft tissue sarcoma)
Clinical study into the use of the dye indocyanine green and near infrared fluorescence during surgery.
Recruiting
Who can enter
Children with a kidney tumor or a soft-tissue tumor near the testicle who are undergoing surgery
All ages
Goal
The goal of this study is to investigate whether the use of the dye indocyanine green and near-infrared fluorescence during surgery makes the procedure easier, more effective, and safer.
Background
Surgery is an important part of treatment for many children with cancer. Surgery may also be necessary to make a diagnosis and determine whether there are metastases.
During surgery, it is often difficult to distinguish between tumor tissue and healthy tissue. If the surgeon needs to remove lymph nodes, it is hard to tell which lymph nodes contain tumor tissue and which do not. As a result, the surgeon may sometimes be unable to remove all of the tumor tissue. Or the surgeon may unnecessarily remove healthy tissue. This can potentially lead to additional complications for the patient or cause long-term adverse effects. That is why we are investigating techniques to make it easier to distinguish between tumor tissue and healthy tissue.
One of the techniques we are investigating is the use of fluorescence-guided surgery. In this procedure, the dye indocyanine green is injected into the tumor, the bloodstream, or the lymphatic fluid near the tumor. This dye accumulates in the tumor tissue and can be visualized using a special camera that operates on near-infrared light. We expect this will enable the surgeon to see the tumor tissue more clearly and perform the surgery more effectively, easily, and safely.
The dye and camera have been used for some time in various surgical procedures in adults. The dye and camera are approved for use in this manner. This technique is safe, and the administration of the dye rarely causes side effects in patients. The dye does not remain visible for long; it is quickly broken down by the body after surgery.
In order to participate in a study please refer to your/your child’s doctor.
Last reviewed
June 16, 2026
Study details
- Study details
Official title
Indocyanine Green and near infrared fLuorescence in paediatric Oncology surgeryCancer type
Kidney tumor
Soft tissue sarcoma (paratesticular rhabdomyosarcoma)
Phase
2Maximum number of participants
290, of whom 30 are expected to participate in the NetherlandsStart date
June 16, 2026Status
OpenLocal principal investigator
Dr. A.F.W. van der SteegSponsor
The University of BirminghamApproval
The study of this new treatment has been reviewed by an accredited medical research ethics committee. This committee has decided that it is justified to ask patients to participate in this study. More information can be found at: CCMO.Trial registry number
EU clinical trial registry: 2024-514089-37-00
The above information is intended as a brief summary only and may not reflect the most up-to-date information. For full details and the current status of a protocol, physicians can contact the Princess Máxima Center directly.